UNSPSC 51392210: Medetomidine

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MR15E85MQM, chemically known as 1h-imidazole, 4-(1-(2,3-dimethylphenyl)ethyl)- but generally known as medetomidine, which bears US NIH Compound Identifier 68602. European Medicines Agency schedules Medetomidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08691MIG.

UNSPSC 51392210 Medetomidine is a Commodity code that captures pharmaceutical products used in emergency medical response and public health contexts, though the recent state and local solicitation activity under this code shows minimal volume and a mismatch between the code's nominal scope and actual procurement need. Seminole County, Florida has posted a competitive bidding solicitation (IFB) for naloxone and safe drug deactivation systems—emergency-response pharmaceuticals unrelated to medetomidine's veterinary and sedative applications—indicating that state and local procurement offices may be tagging emergency pharmaceutical and harm-reduction product acquisitions to this code despite classification misalignment. The work typically involves bulk procurement of pharmaceutical supplies for public health departments, community health centers, emergency services, and substance-abuse intervention programs, with vendors handling compliance certification, supply chain logistics, and quarterly or recurring delivery schedules.

Seminole County represents the only recent documented state and local opportunity under this code in the dataset. The solicitation (IFB 60459723LAS, posted June 30, 2026, with response deadline July 26, 2023) called for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the contract included a two-year initial term with one-year renewal option, E-Verify compliance, drug-free workplace certification, and standard commercial insurance requirements. The narrow activity level and single-jurisdiction footprint suggest this code receives infrequent state and local procurement use, and bidders should verify code accuracy against actual purchasing categories at target agencies before responding to opportunities tagged to it.